Luskin A, Griffin NM, Wagele-Steffen A, et al. Decreased exacerbations and hospitalizations in adolescents enrolled in PROSPERO (Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab). ATS 2017, abstract A5104.
Hoge dosis rifampicine leidt niet tot minder sterfte bij tuberculeuze meningitis
jan 2026 | Bacteriële infecties, Tuberculose